extract: 2025-10-02-kiutra-he3-free-adr-commercial-deployment
Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>
This commit is contained in:
parent
b6dd53e04e
commit
10ee06327b
1 changed files with 15 additions and 1 deletions
|
|
@ -7,9 +7,13 @@ date: 2025-10-02
|
||||||
domain: space-development
|
domain: space-development
|
||||||
secondary_domains: []
|
secondary_domains: []
|
||||||
format: article
|
format: article
|
||||||
status: unprocessed
|
status: null-result
|
||||||
priority: medium
|
priority: medium
|
||||||
tags: [helium-3, adr, quantum-computing, cryogenics, commercial-deployment, kiutra, substitution]
|
tags: [helium-3, adr, quantum-computing, cryogenics, commercial-deployment, kiutra, substitution]
|
||||||
|
processed_by: astra
|
||||||
|
processed_date: 2026-03-19
|
||||||
|
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||||
|
extraction_notes: "LLM returned 0 claims, 0 rejected by validator"
|
||||||
---
|
---
|
||||||
|
|
||||||
## Content
|
## Content
|
||||||
|
|
@ -49,3 +53,13 @@ PRIMARY CONNECTION: Pattern 4 He-3 demand robustness — most direct evidence th
|
||||||
WHY ARCHIVED: Commercial deployment at research institutions is the key fact — this moves ADR from speculative to proven-in-limited-context. The remaining question is scale-up to data-center quantum computing.
|
WHY ARCHIVED: Commercial deployment at research institutions is the key fact — this moves ADR from speculative to proven-in-limited-context. The remaining question is scale-up to data-center quantum computing.
|
||||||
|
|
||||||
EXTRACTION HINT: Extract as "experimental" confidence claim — ADR is proven at research scale, not yet at commercial quantum computing scale. The extractor should acknowledge kiutra's deployment while noting the scale gap to Interlune's target market.
|
EXTRACTION HINT: Extract as "experimental" confidence claim — ADR is proven at research scale, not yet at commercial quantum computing scale. The extractor should acknowledge kiutra's deployment while noting the scale gap to Interlune's target market.
|
||||||
|
|
||||||
|
|
||||||
|
## Key Facts
|
||||||
|
- Kiutra raised €13M ($15.2M) in October 2025
|
||||||
|
- Round led by NovaCapital (Italy) and 55 North (Denmark), with HTGF (Germany)
|
||||||
|
- Total funding exceeds €30M
|
||||||
|
- Kiutra is based in Munich, Germany
|
||||||
|
- He-3 is produced primarily from tritium decay in US and Russian nuclear stockpiles
|
||||||
|
- He-3 supply constraints have affected experimental physics for 15+ years
|
||||||
|
- NATO and EU have flagged He-3 as a quantum technology supply chain risk
|
||||||
|
|
|
||||||
Loading…
Reference in a new issue